Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Delphine Chaillou

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Bulletin Du Cancer|January 29, 2019
Marie-Émilie Dourthe, Karima Yakouben, Delphine Chaillou, et al.
Bulletin Du Cancer|September 22, 2018
Marie Émilie Dourthe, Karima Yakouben, Delphine Chaillou, et al.
Bulletin Du Cancer|May 2, 2021
[A standardized medical report template for CAR T-Cell therapy patients: Guidelines of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Florence Broussais, Alyette Vasseur, Micheline Karam, et al.
Bulletin Du Cancer|December 14, 2019
[Reporting data of patients receiving CAR T cell therapy into the EBMT registry: Guidelines of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Alyette Vasseur, Micheline Karam, Delphine Chaillou, et al.
British Journal of Haematology|May 12, 2024
Success of donor-derived CAR-T cells after failure of autologous CD19 CAR-T cells (tisagenlecleucel) in B-cell acute lymphoblastic leukaemiaMarie Emilie Dourthe, Karima Yakouben, Audrey David, et al.
Leukemia|May 18, 2021
Determinants of CD19-positive vs CD19-negative relapse after tisagenlecleucel for B-cell acute lymphoblastic leukemiaMarie-Emilie Dourthe, Florence Rabian, Karima Yakouben, et al.
Leukemia|February 24, 2026
Characteristics and outcome determinants in children, adolescents and young adults who failed tisagenlecleucel for B-cell acute lymphoblastic leukemiaNicolas Lecornec, Florence Rabian, Marie-Emilie Dourthe, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Bulletin Du Cancer|January 29, 2019
Marie-Émilie Dourthe, Karima Yakouben, Delphine Chaillou, et al.
Bulletin Du Cancer|September 22, 2018
Marie Émilie Dourthe, Karima Yakouben, Delphine Chaillou, et al.
Bulletin Du Cancer|May 2, 2021
[A standardized medical report template for CAR T-Cell therapy patients: Guidelines of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Florence Broussais, Alyette Vasseur, Micheline Karam, et al.
Bulletin Du Cancer|December 14, 2019
[Reporting data of patients receiving CAR T cell therapy into the EBMT registry: Guidelines of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Alyette Vasseur, Micheline Karam, Delphine Chaillou, et al.
British Journal of Haematology|May 12, 2024
Success of donor-derived CAR-T cells after failure of autologous CD19 CAR-T cells (tisagenlecleucel) in B-cell acute lymphoblastic leukaemiaMarie Emilie Dourthe, Karima Yakouben, Audrey David, et al.
Leukemia|May 18, 2021
Determinants of CD19-positive vs CD19-negative relapse after tisagenlecleucel for B-cell acute lymphoblastic leukemiaMarie-Emilie Dourthe, Florence Rabian, Karima Yakouben, et al.
Leukemia|February 24, 2026
Characteristics and outcome determinants in children, adolescents and young adults who failed tisagenlecleucel for B-cell acute lymphoblastic leukemiaNicolas Lecornec, Florence Rabian, Marie-Emilie Dourthe, et al.
Pageof 1